View Older Stories

Jan 21, 2026 09:05AM Insmed (INSM) PT Raised to $200 at RBC Capital

Jan 12, 2026 09:33AM Truist on Insmed (INSM): Brinsupri Launch Outpacing Most Bullish Expectations

Jan 9, 2026 07:02AM Insmed reports strong BRINSUPRI launch with $172.7 million in revenue

Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC

Jan 6, 2026 04:34AM Leerink Partners Reiterates Top Pick on Insmed (INSM)

Dec 19, 2025 06:54AM Goldman Sachs Reiterates Buy Rating on Insmed (INSM)

Dec 19, 2025 02:24AM Truist Securities Assumes Insmed (INSM) at Buy

Dec 18, 2025 10:19AM Insmed (INSM) PT lowered to $230 at H.C. Wainwright

Dec 18, 2025 08:08AM Insmed (INSM) PT Lowered to $241 at TD Cowen as 'Ph2 Brenso BiRCh Misses'

Dec 18, 2025 07:30AM Insmed (INSM) PT Lowered to $212 at Mizuho, 'We're Buyers on Weakness'

Dec 18, 2025 07:11AM Insmed's (INSM) Brensocatib Trial a Disappointment - Stifel

Dec 18, 2025 06:58AM Insmed's (INSM) Brenso Negative Phase 2 Readout A Setback - Cantor Fitzgerald

Dec 18, 2025 06:25AM Insmed (INSM) PT Lowered to $203 at BofA Securities

Dec 18, 2025 04:19AM Insmed (INSM) PT Lowered to $195 at RBC Capital

Dec 18, 2025 04:11AM Insmed (INSM) PT Lowered to $195 at Leerink Partners

Dec 18, 2025 03:53AM Insmed (INSM) PT Lowered to $167 at Wolfe Research

Dec 17, 2025 04:01PM Insmed discontinues nasal polyps drug program after trial fails

Dec 17, 2025 04:01PM Insmed (INSM) halted, news pending

Dec 16, 2025 06:48AM Insmed (INSM) PT Raised to $230 at Cantor Fitzgerald Brenso Potential

Dec 15, 2025 08:44AM Western Digital stock rises after inclusion in Nasdaq-100 Index

Dec 15, 2025 03:46AM Goldman Sachs Reiterates Buy Rating on Insmed (INSM)

Dec 10, 2025 09:24AM 'Insmed's (INSM) Quad Shot At Significant Upside'; PT Raised to $269 at TD Cowen

Dec 4, 2025 03:26AM Rothschild Redburn Starts Insmed (INSM) at Buy

Dec 1, 2025 05:35AM Insmed (INSM) PT Raised to $256 at Mizuho

Nov 18, 2025 11:00AM European Commission approves Insmed's BRINSUPRI for bronchiectasis

Nov 18, 2025 09:37AM Insmed (INSM) PT Raised to $227 at Leerink Partners

Oct 31, 2025 09:59AM Insmed (INSM) PT Raised to $223 at UBS

Oct 30, 2025 03:00PM Insmed (INSM) PT Raised to $223 at TD Cowen

Oct 30, 2025 07:11AM Insmed (INSM) Misses Q3 EPS by 41c, provide guidance

Oct 28, 2025 09:02AM Cantor Fitzgerald Assumes Insmed (INSM) at Overweight

Oct 20, 2025 09:44AM UBS Reiterates Buy Rating on Insmed (INSM)

Oct 17, 2025 07:01AM European regulators recommend Insmed's BRINSUPRI for rare lung disease

Oct 14, 2025 09:47AM Insmed (INSM) PT Raised to $194 at UBS

Oct 2, 2025 04:16AM Insmed (INSM) PT Raised to $193 at TD Cowen

Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Sep 8, 2025 07:22AM Insmed (INSM) PT Raised to $172 at Guggenheim, 'continue to see it as a Top Pick'

Sep 3, 2025 05:20AM Cadence Design Systems (CDNS) Goldman Updates September Directors Cut Conviction List for US

Aug 20, 2025 04:28PM Insmed (INSM) PT Raised to $144 at Morgan Stanley

Aug 20, 2025 01:10AM William Blair Starts Insmed (INSM) at Outperform

Aug 14, 2025 11:06AM Insmed (INSM) PT Raised to $139 at Truist; 'We Remain Buyers'

Aug 14, 2025 06:48AM Insmed (INSM) PT Raised to $240 at H.C. Wainwright

Aug 14, 2025 06:04AM Insmed (INSM) PT Raised to $173 at Wolfe Research

Aug 14, 2025 05:55AM Insmed (INSM) PT Raised to $145 at Stifel

Aug 13, 2025 10:25AM Insmed (INSM) PT Raised to $154 at TD Cowen Following Brinsupri Approval

Aug 13, 2025 09:54AM RBC Capital on Insmed's (INSM) Brinsupri Approval: 'Stock PT To $138.00, Buyers Into The Launch'

Aug 13, 2025 06:38AM Insmed (INSM) PT Raised to $165 at Mizuho

Aug 13, 2025 05:21AM Insmed (INSM) PT Raised to $140 at Wells Fargo

Aug 13, 2025 05:19AM Insmed (INSM) PT Raised to $140 at UBS

Aug 13, 2025 01:58AM Morgan Stanley Downgrades Insmed (INSM) to Equalweight

View Older Stories